Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies

Cancer Genetics

Volumn 204, Issue 1, 2011, Pages 26-38

  Dougherty, Margaret J ^a   Wilmoth, Donna M ^a   Tooke, Laura S ^a   Shaikh, Tamim H ^b   Gai, Xiaowu ^a   Hakonarson, Hakon ^a,c   Biegel, Jaclyn A ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BCL6; CDKN2A b; Genome wide array; SNP array; TAL1

Indexed keywords

ACCURACY; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BONE MARROW BIOPSY; CANCER PROGNOSIS; CDKN2A GENE; CDKN2B GENE; CHILD; CHILD HEALTH CARE; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; COPY NUMBER VARIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IKZF1 GENE; KARYOTYPING; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; PAX5 GENE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA; TUMOR GENE; VALIDATION PROCESS; BIOLOGICAL MODEL; BLOOD DISEASE; DNA MICROARRAY; GENE DOSAGE; GENE TRANSLOCATION; GENETICS; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROSPECTIVE STUDY;

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BCL6 PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA BINDING PROTEIN; ONCOPROTEIN; TAL1 PROTEIN, HUMAN;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENE DELETION; GENE DOSAGE; GENOME-WIDE ASSOCIATION STUDY; HEMATOLOGIC NEOPLASMS; HUMANS; KARYOTYPING; MODELS, GENETIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; TRANSLOCATION, GENETIC;

EID: 79955666046     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.10.007     Document Type: Article

References (34)

1. Raghaven M, Lillington DM, Skoulakis S, et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005;65:375-378.
2. Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 2008;111:776-784.
3. Irving JAE, Bloodworth L, Brown NP, et al. Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis. Cancer Res 2005;65:3053-3058.
4. Pfeifer D, Pantic M, Skatulla I, et al. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 2007;109:1202-1210.
5. Gondek LP, Tiu R, O'Keefe CL, et al. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 2008;111:1534-1542.
6. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alteration in acute lymphoblastic leukaemia. Nature 2007;446:758-764.
7. Sievert AJ, Jackson EM, Gai X, et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 2009;19:449-458.
8. Peiffer DA, Le JM, Steemers FJ, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium wholegenome genotyping. Genome Res 2006;16:1136-1148.
9. Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009;19: 1682-1690.
10. Pui CH, Williams DL, Raimondi SC, et al. Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1987;70:247-253.
11. Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 2009;27:5202-5207.
12. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2006; 360:470-480.
13. Baron BW, Nucifora G, McCabe N, et al. Identification of the gene associated with the recurring chromosomal translocations t(3;14) (q27;q32) and t(3;22) (q27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 1993;90:5262-5266.
14. Kerkaert JP. BCL6(B-Cell Lymphoma 6). Atlas Genet Cytogenet Oncol Haematol. Available at: http://AtlasGeneticsOncology.org/Genes/BCL6ID20.html.Accessed on July 20, 2010.
15. Knezevich S. BCL6(B-Cell Lymphoma 6). Atlas Genet Cytogenet Oncol Haematol. Available at: http://AtlasGeneticsOncology.org/Genes/BCL6ID20.html. Accessed on July 20, 2010.
16. Bash RO, Crist WM, Shuster JJ, et al. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a pediatric oncology group study. Blood 1993;81:2110-2117.
17. Aplan PD, Lombardi DP, Ginsberg AM, et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 1990;250:1426-1429.
18. Begley CG, Aplan PD, Davey MP, et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 1989;86:2031-2035.
19. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital abnormalities. Am J Hum Genet 2010;86:749-e764.
20. INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse. Blood 2001;97:572-574.
21. INKB in relapsed childhood acute lymphoblastic leukemia. Blood 2002;99:4629-4631.
22. Usvasalo A, Ninomiya S, Räty R, et al. Focal 9p instability in hematologic neoplasias revealed by comparative genomic hybridization and single-nucleotide polymorphism microarray analyses. Genes Chromosomes Cancer 2010;49:309-318.
23. Schiffman JD, Wang Y, McPherson LA, et al. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia. Cancer Genet Cygogenet 2009;193:9-18.
24. Nutt SL, Heavey B, Rolink AG, et al. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401:556-562.
25. Busslinger M. Transcriptional control of early B-cell development. Annu Rev Immunol 2004;22:55-79.
26. Mikkola I, Heavey B, Horcher M, et al. Reversion of B-cell commitment upon loss of Pax5 expression. Science 2002;297:110-113.
27. Barberis A, Widenhorn K, Vitelli L, et al. A novel B-cell lineagespecific transcription factor present at early but not late stages of differentiation. Genes Dev 1990;4:849-859.
28. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453:110-115.
29. Weiss A, Newton M, Crommie D. Expression of T3 in association with a molecule distinct from the T-cell antigen receptor heterodimer. Proc Natl Acad Sci USA 1986;83:6998-7002.
30. Moingeon P, Ythier A, Goubin G, et al. A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature 1986;323:638-640.
31. Bank I, DePinho RA, Brenner MB, et al. A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes. Nature 1986;322:179-181.
32. Brenner MB, McLean J, Dialynas DP, et al. Identification of a putative second T-cell receptor. Nature 1986;322:145-149.
33. Marrack P, Kappler J. The T cell receptor. Science 1987;238: 1073-1079.
34. Weiss A. Structure and function of the T cell antigen receptor. J Clin Invest 1990;86:1015-1022.